NIH-funded research R01 grant

Investigating how non-coding RNAs help protect against Alzheimer’s Disease

Official title: Non-coding RNAs in resilience to Alzheimer’s Disease

Funded at Beth Israel Deaconess Medical Center · NIH-11043418 · Data updated 2026-11-12

This study is looking at how certain tiny molecules in our genes might help some older people stay sharp and think clearly even when they have changes in their brains related to Alzheimer’s Disease, with the hope of finding ways to keep everyone’s mind healthy as they age.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startMay 15, 2023
Project endFebruary 28, 2028
Funding year2025
Award (this year)$827,394
NIH project number5R01AG082093-03
Project IDNIH-11043418 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are elderly individuals who are cognitively healthy despite having Alzheimer’s-related brain changes.

Less likely to help

Patients who are already experiencing significant cognitive decline or have advanced Alzheimer's Disease may not benefit from this research.

What this research studies

This research focuses on understanding the role of non-coding RNAs in enhancing resilience to Alzheimer’s Disease (AD). It aims to identify specific non-coding RNA regulators that help individuals maintain cognitive function despite the presence of AD-related brain changes. By studying a unique group of elderly individuals who remain cognitively intact, the research seeks to uncover mechanisms that could prevent cognitive decline. The approach involves analyzing gene expression and regulatory processes that are crucial for brain health as people age.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or delaying cognitive decline in Alzheimer’s Disease.

How similar studies have gone: Previous research has shown promise in understanding the role of non-coding RNAs in various diseases, suggesting potential for success in this novel approach to Alzheimer’s Disease.

Where this research is happening

  • Beth Israel Deaconess Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Slack, Frank J. — Beth Israel Deaconess Medical Center
  • Study coordinator: Slack, Frank J.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.